Current position:Home >Product >
Carbamic acid, [5-(4-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepin-3-yl]-, phenylmethyl ester
Carbamic acid, [5-(4-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepin-3-yl]-, phenylmethyl ester(209985-45-5)
- Name: Carbamic acid, [5-(4-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepin-3-yl]-, phenylmethyl ester
- Synonyms:
- Molecular Formula:C23H18FN3O3
- Molecular Weight:403.413
- CAS Registry Number:209985-45-5
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 209973-05-7/1H-Isoindole-1,3(2H)-dione, 2-[(6-hydroxyhexyl)oxy]-
- 209974-81-2/2H-1-Benzopyran-2-one, 7-hydroxy-3-(2-phenyl-4-thiazolyl)-
- 209974-85-6/6-hexyl-7-hydroxy-3-(2-phenyl-1,3-thiazol-4-yl)-2H-chromen-2-one
- 209984-05-4/2H-1-Benzazepin-2-one, 3-amino-1,3,4,5-tetrahydro-5-methyl-
- 209984-06-5/Carbamic acid, (2,3,4,5-tetrahydro-5-methyl-2-oxo-1H-1-benzazepin-3-yl)-, 1,1-dimethylethyl ester
- 209984-07-6/Carbamic acid, (2,3,4,5-tetrahydro-1,5-dimethyl-2-oxo-1H-1-benzazepin-3-yl)-, 1,1-dimethylethyl ester
- 209984-08-7/2H-1-Benzazepin-2-one, 3-amino-1,3,4,5-tetrahydro-1,5-dimethyl-
- 209985-11-5/1H-1,4-Benzodiazepine-2,3-dione, 1-methyl-5-(1-piperidinyl)-, 3-[O-[(ethylamino)carbonyl]oxime]
- 209985-17-1/Carbamic acid, (7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3 -yl)-, phenylmethyl ester
- 209985-21-7/Carbamic acid, [(1S)-2-[[7-bromo-5-(2-fluorophenyl)-2,3-dihydro-1-methyl-2-oxo-1H-1,4 -benzodiazepin-3-yl]amino]-1-methyl-2-oxoethyl]-, 1,1-dimethylethyl ester
- 209985-26-2/Carbamic acid, [(1S)-2-[[7-chloro-5-(2-chlorophenyl)-2,3-dihydro-1-methyl-2-oxo-1H-1,4 -benzodiazepin-3-yl]amino]-1-methyl-2-oxoethyl]-, 1,1-dimethylethyl ester
- 209985-28-4/(R,S)-Z-3-AMINO-7-CHLORO-5-(2-CHLOROPHENYL)-2-OXO-1,4-BENZODIAZEPINE
- 209985-31-9/Carbamic acid, [2-[(2-benzoyl-4-nitrophenyl)amino]-1-[(1-methylethyl)thio]-2-oxoethyl]-, phenylmethyl ester
- 209985-33-1/Carbamic acid, (2,3-dihydro-1-methyl-7-nitro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl )-, phenylmethyl ester
- 209985-36-4/2H-1,4-Benzodiazepin-2-one, 3-amino-5-(2-fluorophenyl)-1,3-dihydro-1-methyl-
- 209985-39-7/Carbamic acid, [2-[[2-(3-fluorobenzoyl)phenyl]amino]-1-[(1-methylethyl)thio]-2-oxoethyl]-, phenylmethyl ester
- 209985-40-0/Carbamic acid, [5-(3-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepin-3-yl]-, phenylmethyl ester
- 209985-41-1/Carbamic acid, [5-(3-fluorophenyl)-2,3-dihydro-1-methyl-2-oxo-1H-1,4-benzodiazepin-3 -yl]-, phenylmethyl ester
- 209985-44-4/Carbamic acid, [2-[[2-(4-fluorobenzoyl)phenyl]amino]-1-[(1-methylethyl)thio]-2-oxoethyl]-, phenylmethyl ester
- 209985-45-5/Carbamic acid, [5-(4-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepin-3-yl]-, phenylmethyl ester
- 209985-46-6/Carbamic acid, [5-(4-fluorophenyl)-2,3-dihydro-1-methyl-2-oxo-1H-1,4-benzodiazepin-3 -yl]-, phenylmethyl ester
- 209986-36-7/Propanamide, 2-amino-N-[1-[(3-fluorophenyl)methyl]-2,3-dihydro-2-oxo-5-phenyl-1H-1, 4-benzodiazepin-3-yl]-, (2S)-
- 209986-37-8/Propanamide, 2-amino-N-[2,3-dihydro-2-oxo-5-phenyl-1-(phenylmethyl)-1H-1,4-benzo diazepin-3-yl]-, (2S)-
- 209986-38-9/Propanamide, 2-amino-N-[1-[[4-(1,1-dimethylethyl)phenyl]methyl]-2,3-dihydro-2-oxo-5- phenyl-1H-1,4-benzodiazepin-3-yl]-, (2S)-
- 209986-44-7/Propanamide, 2-amino-N-[2,3-dihydro-2-oxo-5-phenyl-1-(2-phenylethyl)-1H-1,4-benzo diazepin-3-yl]-, (2S)-
- 209986-47-0/Propanamide, 2-amino-N-[1-([1,1'-biphenyl]-2-ylmethyl)-2,3-dihydro-2-oxo-5-phenyl-1 H-1,4-benzodiazepin-3-yl]-, (2S)-
- 209986-48-1/Propanamide, 2-amino-N-[2,3-dihydro-2-oxo-5-phenyl-1-[(tetrahydro-2-furanyl)methyl]- 1H-1,4-benzodiazepin-3-yl]-, (2S)-
- 209986-49-2/Propanamide, 2-amino-N-[1-[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]-2,3-dihydro-2- oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-, (2S)-
- 209986-50-5/Propanamide, 2-amino-N-[1-[(5-chlorobenzo[b]thien-3-yl)methyl]-2,3-dihydro-2-oxo-5- phenyl-1H-1,4-benzodiazepin-3-yl]-, (2S)-
- 209986-51-6/Propanamide, 2-amino-N-[1-(3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-phenyl-1H- 1,4-benzodiazepin-3-yl]-, (2S)-